Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

<< Previous
Bullboard Posts
Next >>
Post by Vinny57on Mar 31, 2020 2:28am
477 Views
Post# 30862949

CRON: a $3.1 billion Market Cap

CRON: a $3.1 billion Market Cap*********ARE YOU KIDDING ME:***********

 

Cronos Group Down 2% After Market As Q4 Operating Loss Widens, Restates Previous Three Quarters

10 hours ago by MT Newswires
 

04:17 PM EDT, 03/30/2020 (MT Newswires) -- Cronos Group (CRON.TO) fell 2% in aftermarket Nasdaq trading after the compny on Monday said its fourth-quarter operating loss widened on charges, even as the cannabis producer's revenue rose 71%.

The company said its operating loss fell to US$63.87 million from US$8.87 million in the year prior quarter. It did not disclose net loss figures. Revenue rose to US$7.31 million from US$4.29 million.

Cronos said the loss included a US$24 million writedown on inventory and US$22.1 million charge on the value of its marijuana plants as well as other writedowns.

The company said that following an audit committee review of of certain bulk resin purchases and sales of products through the wholesale channel", it has restated revenue for the first three quarters of the year, cutting first-quarter revenue by C$2.5 million and third-quarter revenue by C$5.1 million.

"As we move forward, we are committed to improving our internal controls and financial reporting practices, maintaining the highest standards of transparency and accountability, and enhancing our capabilities and resources across functions to support our strategy," chief executive Mike Gorenstein said in a release.

Cronos shares were last seen down US$0.13 to US$6.21 in aftermarket Nasdaq trading. The shares closed up C$0.20 to C$9.02 on the Toronto Stock Exchange.

Price: 9.02, Change: +0.20, Percent Change: +2.27


*******OUR MARKET CAP IS 1/3 THE SIZE............ TALK ABOUT UNDERVALUED******
<< Previous
Bullboard Posts
Next >>